We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
+94.37%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
–
AUM
$3.62B
AUM Growth
+$178M
Cap. Flow
-$688M
Cap. Flow %
-19%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$628M
2
DNLI icon
Denali Therapeutics
DNLI
+$60.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
1
Moderna
MRNA
$21.5B
$2.18B 60.34%
30,871,524
-9,000,000
-23% -$628M
MCRB icon
2
Seres Therapeutics
MCRB
$48.1M
$611M 16.87%
1,078,588
– –
KLDO
3
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$214M 5.92%
19,360,710
– –
DNLI icon
4
Denali Therapeutics
DNLI
$3.67B
$214M 5.92%
5,980,263
-2,000,000
-25% -$60.2M
RUBY
5
DELISTED
Rubius Therapeutics, Inc
RUBY
$192M 5.3%
38,296,526
– –
EVLO
6
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$121M 3.33%
1,145,003
– –
AXLA
7
DELISTED
Axcella Health Inc. Common Stock
AXLA
$58M 1.6%
501,937
– –
SYRS
8
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$26M 0.72%
293,849
– –

Similar funds

AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.16B AUM 0.86% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $1.16B AUM 13.88% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
FFP
FourThought Financial Partners Venice, Florida $1.16B AUM 24.95% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Flagship Pioneering's Q3 2020 Portfolio in Review

As of Q3 2020, Flagship Pioneering held 8 positions worth $3.62B, up 5.2% from $3.44B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Pioneering withdrew a net $688M in Q3 2020, reducing 2 holdings. Its largest reduction was Moderna, cutting an estimated $628M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Flagship Pioneering's biggest Q3 2020 reduction was Moderna, cutting an estimated $628M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $3.62B portfolio in Q3 2020.
  • Flagship Pioneering opened 0 new positions and closed 0 in Q3 2020.
  • Flagship Pioneering's portfolio value rose 5.2% quarter-over-quarter to $3.62B.

Based on Flagship Pioneering's 13F filing for Q3 2020, filed 16 Nov 2020.